Inventor

NIAZI KAYVAN

US91 patents

⚠️ This page may combine multiple inventors who share the name “NIAZI KAYVAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NIAZI KAYVAN

NANT HOLDINGS IP LLC

Compositions and methods for reduction of allograft recognition and rejection

Coordinated multi-prong cancer therapy

Nant cancer vaccine

Compositions and methods for viral delivery of neoepitopes and uses thereof

Recombinant NK cells expressing co-stimulatory molecules

Compositions and methods for reduction of allograft recognition and rejection

Calcium flux agonists and methods therefor

Small molecule inhibitors of influenza A RNA-dependent RNA polymerase

Small molecule inhibitors of influenza A RNA-dependent RNA polymerase

Recombinant NK cells expressing co-stimulatory molecules

Live cell imaging systems and methods to validate triggering of immune response

Compositions and methods for viral delivery of neoepitopes and uses thereof

NK cells with altered CXCL12/CXCR4 signaling

NANTCELL INC

Maximizing T-cell memory and compositions and methods therefor

Sequence arrangements and sequences for neoepitope presentation

HIV treatment compositions and methods

Production and delivery tracking and sample verification of patient-specific therapeutics

Recombinant erIL-15 NK cells

Targeted neoepitope vectors and methods therefor

Targeted neoepitope vectors and methods therefor

Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence

Production and delivery tracking and sample verification of patient-specific therapeutics

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

Production and delivery tracking and sample verification of patient-specific therapeutics

Nant cancer vaccine

Hypoxic NK cells and methods therefor

NANTBIO INC

Multi-pulse transfection methods and cells

Cellular adjuvants for viral infection

mRNA display antibody library and methods

Anti-TIM3 monoclonal antibodies and chimeric antigen receptors

Anti-IL8 antibodies

Mesenchymal stem cell derived exosomes and methods

Live cell imaging systems and methods to validate triggering of immune response

Reprogrammed T cell-like NK cells

Mesenchymal stem cell derived exosomes and methods

mRNA display antibody library and methods

Cellular adjuvants for viral infection

NANTOMICS LLC

Cancer neoepitopes

Tumor antigenicity processing and presentation

Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor

Method of treating a tumor in a patient based on an immune gene expression

Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor

Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors

High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies

CHAN SOON SHIONG NANTHEALTH FOUND

Compositions and methods of improved wound healing

NIAZI KAYVAN

Small molecule inhibitors of influenza A RNA-dependent RNA polymerase

RABIZADEH SHAHROOZ

Compositions and methods of targeting mutant K-Ras

NantCell

Recombinant erIL-15 NK cells

NANOCAV LLC

Methods of sorting activated T cells using three dimensional dielectrophoresis

CHAN SOON SHIONG INST OF ADVANCED HEALTH

Compositions and methods of improved wound healing